• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Nanoformulation Containing an Exosome-Derived Monoclonal Antibody

Nanoformulation Containing an Exosome-Derived Monoclonal Antibody

Paperback

Medical Reference

ISBN10: 6138395395
ISBN13: 9786138395393
Publisher: Scholars' Press
Published: Oct 2 2025
Pages: 144
Weight: 0.44
Height: 0.34 Width: 6.00 Depth: 9.00
Language: English
The book introduces an innovative approach to overcoming therapeutic resistance in one of the most aggressive brain cancers. This book explores how nanotechnology, exosome engineering, and targeted delivery systems can be combined to improve drug transport across the blood-brain barrier. It emphasizes the role of exosome-derived monoclonal antibodies and TfR-targeting ligands in enhancing specificity, stability, and therapeutic efficacy for glioblastoma treatment. The text integrates concepts from molecular biology, oncology, pharmacology, and bioengineering, providing a multidisciplinary perspective on translational applications. With a focus on precision medicine, the book outlines preclinical insights, potential clinical strategies, and future directions for nanoformulated therapies that bridge diagnostics and therapeutics. It serves as a valuable resource for researchers, clinicians, and graduate students seeking to advance glioblastoma treatment through cutting-edge nanomedicine platforms.

Also from

Aghazadeh, Hamed

Also in

Medical Reference